
Current Price | $0.33 | Mkt Cap | $5.0M |
---|---|---|---|
Open | $0.34 | P/E Ratio | -0.80 |
Prev. Close | $0.33 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.33 - $0.35 | Volume | 12,368 |
52-Wk Range | $0.31 - $1.09 | Avg. Daily Vol. | 36,825 |
A biopharmaceutical company developing proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, bone disease and other disorders.
Current Price | $0.33 | Mkt Cap | $5.0M |
---|---|---|---|
Open | $0.34 | P/E Ratio | -0.80 |
Prev. Close | $0.33 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $0.33 - $0.35 | Volume | 12,368 |
52-Wk Range | $0.31 - $1.09 | Avg. Daily Vol. | 36,825 |
The best Bull and Bear pitches based on recency and number of recommendations.
I may be playing Taps for Titan prematurely, but it's only CAPS and I don't have much to lose. I read over the last earnings call transcript and the tone didn't sound very rosy. Probuphine was launched before the end of the second quarter, yet… More
Read the most recent pitches from players about TTNP.
Recs
Titan has another chance at approval for Probuphine. The FDA rejected the drug in 2013, but after a favorable phase 3 study that wrapped up in the first half of 2015 things are looking up again. Their patented competitive advantage, ProNeura, is the real foolish reason for investing in the company. They hold a patent until 2024 for an implantable steady release of Dopamine Agonist. In my opinion this is a great growth company. Completely off the radar of many investors.
Recs
nev
Recs
The scheduled meeting on 11/15/13 with the FDA will be positive.
Find the members with the highest scoring picks in TTNP.
longtermgrowth09 (60.55) Score: +411.92
The Score Leader is the player with the highest score across all their picks in TTNP.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
longtermgrowth09 | 60.55 | 12/17/2009 |
![]() |
5Y | $69.96 | -99.53% | +312.39% | +411.92 | 0 Comment | |
IvegotCanines | 77.07 | 10/14/2011 |
![]() |
5Y | $39.60 | -99.17% | +276.48% | +375.65 | 0 Comment | |
DorminABC | 99.74 | 3/16/2011 |
![]() |
NS | $48.84 | -99.32% | +261.02% | +360.34 | 0 Comment | |
mrpiddler | 71.99 | 5/25/2011 |
![]() |
NS | $64.35 | -99.49% | +247.44% | +346.92 | 0 Comment | |
Table41 | 83.66 | 3/28/2011 |
![]() |
3M | $50.16 | -99.34% | +247.01% | +346.36 | 0 Comment | |
Dormin111ob | 27.25 | 3/4/2011 |
![]() |
NS | $54.12 | -99.39% | +246.59% | +345.98 | 0 Comment | |
2nufool | 66.15 | 12/8/2006 |
![]() |
3W | $117.18 | -99.72% | +243.47% | +343.19 | 0 Comment | |
goofy4200 | 90.58 | 12/12/2006 |
![]() |
NS | $104.94 | -99.69% | +243.35% | +343.03 | 0 Comment | |
3acrerock | 71.85 | 1/3/2007 |
![]() |
1Y | $107.58 | -99.69% | +238.70% | +338.40 | 0 Comment | |
KidJones | 27.10 | 7/10/2013 |
![]() |
5Y | $21.41 | -98.46% | +176.78% | +275.24 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.